Pain Therapeutics Inc (PTIE)

0.59
0.00 0.68
NASDAQ : Health Care
Prev Close 0.59
Open 0.59
Day Low/High 0.57 / 0.60
52 Wk Low/High 1.53 / 2.72
Volume 154.27K
Avg Volume 918.40K
Exchange NASDAQ
Shares Outstanding 46.14M
Market Cap 26.76M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

For Pain Therapeutics CEO, 3 FDA Rejections Are Worth $23 Million

For Pain Therapeutics CEO, 3 FDA Rejections Are Worth $23 Million

Failure is very profitable for Pain Therapeutics CEO Remi Barbier.

Putting 2 Biotechs Under the Microscope

These low-dollar biotech stocks are making big moves Monday -- in opposite directions.

Complete Response Letter For REMOXY®

Complete Response Letter For REMOXY®

Company Will Host Conference Call Monday, September 26th at 9:00am EDT

DURECT Provides REMOXY® Update

DURECT Provides REMOXY® Update

Pain Therapeutics Announced today that an FDA Advisory Committee Meeting for REMOXY® is Not Needed and No Change to September 25, 2016 PDUFA Date

Pain Therapeutics Announces Advisory Committee Meeting For REMOXY® Is Not Needed

Pain Therapeutics Announces Advisory Committee Meeting For REMOXY® Is Not Needed

No Change to September 25th PDUFA Date

DURECT Announces FDA Advisory Committee Meeting For REMOXY®

DURECT Announces FDA Advisory Committee Meeting For REMOXY®

FDA's Tentative Date for Advisory Committee Meeting is August 5, 2016 and No Change to PDUFA Date of September 25, 2016

Pain Therapeutics Reports 2015 Financial Results And Corporate Update

Pain Therapeutics Reports 2015 Financial Results And Corporate Update

Focus in 2016 Will be on REMOXY, Fiscal Discipline and Advancing Pipeline

Pain Therapeutics Reports Q3 2015 Financial Results And Update On REMOXY

Pain Therapeutics Reports Q3 2015 Financial Results And Update On REMOXY

Focus Remains on NDA Resubmission to FDA, Targeted for Q1 2016

Short Interest In Pain Therapeutics Makes 27.2% Move

Short Interest In Pain Therapeutics Makes 27.2% Move

The most recent short interest data has been released by the NASDAQ for the 05/29/2015 settlement date, which shows a 650,044 share increase in total short interest for Pain Therapeutics Inc , to 3,037,711, an increase of 27.23% since 05/15/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Pain Therapeutics Announces Update On Drug Portfolio

Pain Therapeutics Announces Update On Drug Portfolio

Conference Call Tomorrow, Tuesday, at 4:30 p.m. Eastern Time

Short Interest Decreases By 20% For PTIE

Short Interest Decreases By 20% For PTIE

The most recent short interest data has been released by the NASDAQ for the 10/31/2014 settlement date, which shows a 383,304 share decrease in total short interest for Pain Therapeutics Inc , to 1,544,923, a decrease of 19.88% since 10/15/2014. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Pain Therapeutics Reports Q3 2014 Financial Results

Pain Therapeutics Reports Q3 2014 Financial Results

Conference Call Today at 3:30 p.m. CT/4:30 pm ET